Skip to search formSkip to main contentSkip to account menu

Encainide

Known as: Encainide [Chemical/Ingredient], 4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide, Benzamide, 4-methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)-, (+-)- 
One of the ANTI-ARRHYTHMIA AGENTS, it blocks VOLTAGE-GATED SODIUM CHANNELS and slows conduction within the His-Purkinje system and MYOCARDIUM.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
The local anesthetic, antiarrhythmic, and acute toxicologic properties of the O-demethyl (ODE), 3-methoxy-O-demethyl (MODE) and N… 
1985
1985
Summary: Encainide (E) is a class I antiarrhythmic agent which is metabolised in humans, with the formation in the majority of… 
1984
1984
The electrophysiological effects of encainide (MJ9067) on canine subendocardial Purkinje fibers surviving infarction were… 
1984
1984
The antiarrhythmic agent encainide produces marked suppression of ventricular arrhythmias in most patients. However, in some with… 
Highly Cited
1983
Highly Cited
1983
The influence of stimulation rate on the ability of mexiletine, disopyramide. and encainide to depress the maximum rate of… 
1983
1983
Differences between the electrophysiologic actions of the antiarrhythmic agent encainide have been reported after short-term… 
1982
1982
Combinations of antiarrhythmic drugs are frequently used to treat refractory ventricular tachycardia (VT), but few scientific… 
Highly Cited
1981
Highly Cited
1981
Encainide is a new agent for treating ventricular arrhythmias. We attempted long-term oral therapy with encainide in 38 patients… 
1981
1981
Summary Encainide, a benzanilide derivative, is a local anesthetic antiarrhythmic drug. To determine its effects on infarcted and… 
1980
1980
The right ventricular epicardial ventricular fibrillation threshold (VFT) was determined during paced supraventricular rhythm…